Concise review: Cell therapies for stroke and traumatic brain injury: Targeting microglia

Stem Cells

Volumn 34, Issue 3, 2016, Pages 537-542

  Savitz, Sean I ^a   Cox, Charles S ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Brain injuries; Microglia; Stem cells; Stroke

Indexed keywords

CELL THERAPY; CEREBROVASCULAR ACCIDENT; DIFFUSION TENSOR IMAGING; FRACTIONAL ANISOTROPY; GRAY MATTER; HUMAN; INFLAMMATION; MICROGLIA; NERVE DEGENERATION; POSITRON EMISSION TOMOGRAPHY; REVIEW; TRAUMATIC BRAIN INJURY; WHITE MATTER; ANIMAL; BIOLOGICAL THERAPY; BRAIN INJURIES, TRAUMATIC; GENETICS; METABOLISM; PATHOLOGY; PROCEDURES; STEM CELL TRANSPLANTATION; STROKE; TRANSPLANTATION;

BIOLOGICAL MARKER;

ANIMALS; BIOMARKERS; BRAIN INJURIES, TRAUMATIC; CELL- AND TISSUE-BASED THERAPY; HUMANS; INFLAMMATION; MICROGLIA; STEM CELL TRANSPLANTATION; STROKE;

EID: 84959249928     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2253     Document Type: Review

References (38)

1. Adecola C, Anrather J,. The immunology of stroke: From mechanisms to translation. Nat Med 2011; 17: 796-808.
2. Gelderblom M, Leypoldt F, Steinbach K, et al., Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009; 40: 1849-1857.
3. Pennypacker KR, Offner H,. The role of the spleen in ischemic stroke. J Cereb Blood Flow Metab 2015; 35: 186-187.
4. Offner H, Subramanian S, Parker SM, et al., Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol 2006; 176: 6523-6531.
5. Ajmo CT Jr, Vernon DO, Collier L, et al., The spleen contributes to stroke-induced neurodegeneration. J Neurosci Res 2008; 86: 2227-2234.
6. Hu X, Leak RK, Shi Y, et al., Microglial and macrophage polarization-New prospects for brain repair. Nat Rev Neurol 2015; 11: 56-64.
7. Loane D, Kumar A, Stocia B, et al., Progressive neurodegeneration after experimental brain trauma: Association with chronic microglial activation. J Neuropathol Exp Neurol 2014; 73: 14-29.
8. Sidaros A, Skimminge A, Liptrot MG, et al., Long-term global and regional brain volume changes following severe traumatic brain injury: A longitudinal study with clinical correlates. Neuroimage 2009; 44: 1-8.
9. Wu TC, Wilde EA, Bigler ED, et al., Longitudinal changes in the corpus callosum following pediatric traumatic brain injury. Dev Neurosci 2010; 32: 361-373.
10. Ding K, Marquez de la Plata C, Wang JY, et al., Cerebral atrophy after traumatic white matter injury: Correlation with acute neuroimaging and outcome. J Neurotrauma 2008; 25: 1433-1440.
11. Schwarting S, Litwak S, Hao W, et al., Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke 2008; 39: 2867-2875.
12. Yang B, Migliati E, Parsha K, et al., Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke. Stroke 2013; 44: 3463-3472.
13. Lee ST, Chu K, Jung KH, et al., Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 2008; 131: 616-629.
14. Broughton BR, Lim R, Arumugam TV, et al., Post-stroke inflammation and the potential efficacy of novel stem cell therapies: Focus on amnion epithelial cells. Front Cell Neurosci 2013; 6. Article 66. 1-9.
15. Bedi S, Walker PA, Shah SK, et al., Autologous bone marrow mononuclear cell therapy attenuates activated microglia/macrophage response and improves spatial learning after traumatic brain injury. J Trauma 2013; 75: 410-416.
16. Bedi SS, Hetz R, Thomas C, et al., Intravenous multipotent adult progenitor cell therapy improves spatial learning after traumatic brain injury. Stem Cells Translational Med 2013; 2: 953-960.
17. Vendrame M, Gemma C, Pennypacker KR, et al., Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp Neurol 2006; 199: 191-200.
18. Schwarting S, Litwak S, Hao W, et al., Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke 2008; 39: 2867-2875.
19. Walker PA, Shah SK, Jimenez F, et al., Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: Preserving the blood:brain barrier via an interaction with splenocytes. Exp Neurol 2010; 225: 341-352.
20. Yang B, Hamilton J, Strong R, et al., Human multipotential bone marrow stem cells exert immunomodulatory effects, prevent splenic contraction, and enhance functional recovery in a rodent model of ischemic stroke. Stroke 2011; 42: E67-E67.
21. Lee ST, Chu K, Jung KH, et al., Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 2008; 131: 616-629.
22. Womble TA, Green S, Shahaduzzaman M, et al., Monocytes are essential for the neuroprotective effect of human cord blood cells following middle cerebral artery occlusion in rat. Mol Cell Neurosci 2014; 59: 76-84.
23. Ohtaki H, Ylostalo JH, Foraker JE, et al., Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci U S A 2008; 105: 14638-14643.
24. Liu GJ, Middleton RJ, Hatty CR, et al., The 18 kDa translocator protein, microglia and neuroinflammation. Brain Pathol 2014; 24: 631-653.
25. Yoder KK, Nho K, Risacher SL, et al., Influence of TSPO genotype on 11C-PBR28 standardized uptake values. J Nuclel Med 2013; 54: 1320-1322.
26. Owen D, Howell, OW, Tang SP, et al., Two binding sites for 3HPBR28 in human brain: Implications for TSPO PET imaging of neuroinflammation. J Cerebral Blood Flow Met 2010; 30: 1608-1618.
27. Kreisl WC, Jenko KH, Hinds CS, et al., A genetic polymorphism for translocator protein 19kDa affects both in vitro and in vivo radioligand binding in human brain to this putative biomarker of neuroinflammation. J Cerebral Blood Flow Met 2013; 33: 53-58.
28. Schroeter M, Dennin MA, Walberer M, et al., Neuroinflammation extends brain tissue at risk to vital peri-infarct tissue: A double tracer [11C]PK11195- and [18F]FDG-PET study. J Cereb Blood Flow Metab 2009; 29: 1216-1225.
29. Cosensa-Nashat M, Zhao ML, Suh HS, et al., Expression of the translocator protein of 18 kDa by microglia, macrophages and astrocytes based on immunohistochemical localization in abnormal human brain. Neuropathol Appl Neurobiol 2009; 35: 306-328.
30. Ramlackhansingh AF, Brooks DJ, Greewood RJ, et al., Inflammation after trauma: Microglial activation and traumatic brain injury. Ann Neurol 2011; 70: 374-383.
31. Loane DJ, Kumar A, Stoica BA, et al., Progressive neurodegeneration after experimental brain trauma: Association with chronic microglial activation. J Neuropathol Exp Neurol 2014; 73: 14-29.
32. Walberer M, Jantzen SU, Backes H, et al., In-vivo detection of inflammation and neurodegeneration in the chronic phase after permanent embolic stroke in rats. Brain Res 2014; 1581: 80-88.
33. Yu C, Zhu C, Zhang Y, et al., A longitudinal diffusion tensor imaging study on Wallerian degeneration of corticospinal tract after motor pathway stroke. Neuroimage 2009; 15; 47: 451-458.
34. Thiel A, Radlinska BA, Paquette C, et al., The temporal dynamics of poststroke neuroinflammation: A longitudinal diffusion tensor imaging-guided PET study with 11C-PK11195 in acute subcortical stroke. J Nucl Med 2010; 51: 1404-1412.
35. Wilde EA, Hunter JV, Newsome MR, et al., Frontal and temporal morphometric findings on MRI in children after moderate to severe traumatic brain injury. J Neurotrauma 2005; 22: 333-344.
36. Cox CS, Baumgartner JE, Harting MT, et al., Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children. Neurosurgery 2011; 68: 588-600.
37. Ewing-Cobbs L, Prasad MR, Swank P, et al., Arrested development and disrupted callosal microstructure following pediatric traumatic brain injury: Relation to neurobehavioral outcomes. Neuroimage 2008; 42: 1305-1315.
38. Bendlin BB, Ries ML, Lazar M, et al., Longitudinal changes in patients with traumatic brain injury assessed with diffusion-tensor and volumetric imaging. Neuroimage 2008; 42: 503-514.